Best Agrolife Ltd. · NSE:BESTAGRO
Best Agrolife — Q2 FY26 Earnings Presentation
19 slides from Best Agrolife's earnings presentation, Nov 13, 2025
Slide 1: Submission letter to NSE and BSE
Samye < Best Afiolife limited CIN : L74110DL1992PLC116773 13th November, 2025 To National Stock Exchange of India Limi ted BSE Limited Exchange Plaza, C-1, Block-G, 25% Floor, P.J. Towers, Bandra - Kurla Complex Bandra (E), Mumbai-400051 Dalal Street, Mumbai-400001 SCRIP CODE: 539660 SCID: RI BESTP A
Slide 2: Best Agrolife
(e Throg, SA” / ", "% 5 3 g% ed % 1 [ 4 Best Agro life L
Slide 3: Disclaimer
The Presentation is to provide the general background information about the company’s activities as at the date of the presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any investor sho
Slide 4: Table of Contents
Table of @ Company Snapshot }_@é Management Comment @ Business Highlights {/}l%} Financial Highlights Way Ahead
Slide 5: Company Snapshot
Snapshot Largest Indian Warehouses Patented Dealers Agrochemical PARS EICH Products Company* Manufacturing units Formulations Employees 3 Year Revenue 7000 MTPA Technical Registrations CAGR 35500 KL Formulation *Agropages Top 20 Indian Agrochemical Companies
Slide 6: Management Comment
=N ¥ Ma nagement Comment ) 2 “In this Kharif season an has once again shown the dependence of Indian agriculture on the and of rains. The errant rains posed , with unexpected as well as extended across key agricultural regions, which in turn the overall demand pattern for agrochemicals. Despite thes
Slide 7: Patented Products
o TRICOLOR™ ORISULAM™ DEFENDER™ NEMAGEN™ Herbicide (GR) Fungicide (WG) Pyriproxyfen - 8% Trifloxystrobin - 10% Bispyribac Sodium - 0.25% Pymetrozine - 30% Chiorantraniliprole - 4.5% Dinotefuran - 5% Difenoconazole - 12.5% Penoxsulam - 0.25% BEEENDER Dinotefuran - 10% Novaluron - 11.5% Diafenthiuron
Slide 8: Business Highlights
ighlights revenue stood at , compared to in , reflecting a . The reduction was due to combination of and The Company’s ongoing to stabilize and inventory have delivered strong results, with inventory levels reduced by , from in to in 3 . representing a e revenue was , compared to in for was 5, in li
Slide 9: Highlights
Highlights M/,&’ y 'il'Yr 3\ Crore) Crore) i ‘ . Q2FY25 Q2FY26 <1 m T« = A\ Q2 FY25 Q2 FY26 ( Crore) Crore) ! l ! ' . \ 95 T - 1 4003 - Q2 FY25 Q2 FY26 Q2 FY25 Q2 FY26 “EBITDA s calculated excluding other income
Slide 10: Branded Business
Branded Business 31% Erai 69% 68% L T Q2 FY25 Q2 FY26 Branded M Institutional Sales T S 62% 9% 38% 51% T T Q2 FY25 Q2 FY26 Patented ™ Non-Patented
Slide 11: Financial Highlights for Q2 FY26
for Q2 FY26 Value (INR Cr) Q2 FY26 Q2 FY25 YoY H1 FY26 Revenue from Operations 516.8 746.6 -30.8% 898.1 1265.9 Gross Margin 169.6 252.1 -32.7% 280.2 3794 EBITDA* 715 1471 -47% 1233 201.7 EBITDA Margin (%) 15% 19.7% -470 Bps 13.7% 16% Profit After Tax 389 947 -58.9% 58.9 115.9 PAT Margin (%) 7.56% 12
Slide 12: Profit and Loss Statement for Q2 FY26
for Q2 FY26 Value (INR Cr) Q2 FY26 Q2 FY25 YoY Revenue from Operations 516.8 746.6 -30.8% Other Income 772 1 Total Revenue 515 748 -31% Cost of Goods Sold 347 495 Employee Benefits Expense 24 29 Other Operating Expenses 68 76 Total Expenses 439 600 EBITDA* 715 1471 EBITDA Margin (%) 15% 20% -470 Bps
Slide 13: Profit and Loss Statement for H1 FY26
for H1 FY26 Value (INR Cr) H1 FY26 Revenue from Operations Other Income Total Revenue Cost of Goods Sold Employee Benefits Expense Other Operating Expenses Total Expenses EBITDA* EBITDA Margin (%) Depreciation and Amortisation Finance Cost Profit Before Tax PBT Margin (%) 9% 5% Profit After Tax 589
Slide 14: Balance sheet
Balance sheet Value (INR Cr) As on Sept 30, 2025 As on Sept 30, 2024 As on Mar 31, 2025 Equity And Liabil ies Share Holders Fund 809 756 758 Non-current Liabilities * Long Term Borrowings * Other Financial Liabilities Total Non-current Liabilities Current Liabilities * Short Term Borrowings * Trade
Slide 15: Key Ratios
EW LIS ) 097 0.52 0.44 Fy23 Fy24 H1 FY26 FY24 FY25 H1 FY26 26% 135 15% 13% 1.21 8% FY23 Fy24 H1 FY26 FY23 FY24 FY25 H1FY26 (Not Annualized) *Formulae: ROCE= EBIT/ Capital Employed*100 (Capital Employed = Total Assets ~ current liabilities + Short term borrowings) Debt to Equity = Total Debt / Shareh
Slide 16: Working Capital Movement
Capital Movement 243 212 210 188 186 185 178 173 176 165 135 131 FY24 FY25 H1FY25 H1 FY26 Inventory Days Cash Coversion Days Working Capital Days
Slide 17: Share price and volume performance
958 911 873 812 770 773 744 783 666 632 618 564 Jun-24 Sep-24 Dec-24 Mar-25 Jun-25 Sep-25 Jun-24 Sep-24 Dec-24 Mar-25 Jun-25 Sep-25
Slide 18: Management Team
Management Team Mr. Vimal Alawadhi Mr. P. N. Karlekar Mr. N Surendra Sai Mr. Vikas Jain Managing Director Director Director Chief Financial Officer A true visionary and a passionate A chemical Engineer from UDCT- one of A passionate technologist and A seasoned finance professional with over two entr
Slide 19: Thank You
e Thank Contact Us: ir@bestagrolife.com (Investor Relations) DISCLAIMER This presentation includes certain forward looking statements and information including statements concerning the outlook for business. The statements are based on certain expectations, assumptions, anticipated developments and